Aukera Therapeutics

Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein-related diseases such as cancer and neurogenerative diseases. Aukera Therapeutics is a spin-off from the Biozentrum of the University of Basel.

Domain

aukera-tx.com

Employees

1-10

Last Funding

$5.7M

Founded

2020

Frequently Asked Questions

What technologies does Aukera Therapeutics use?+

Aukera Therapeutics uses 5 technologies including Cloudflare, Google Font API, Open Graph.

What industry is Aukera Therapeutics in?+

Aukera Therapeutics operates in the Biotechnology industry.

Where is Aukera Therapeutics based?+

Aukera Therapeutics is headquartered in Switzerland.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026